Four new members join PhRMA board
This article was originally published in SRA
Executive Summary
The board of directors of US industry association PhRMA has four new members. They are Ian Read, president and chief executive of Pfizer, Novo Nordisk president Jerzy Gruhn, Lundbeck president Staffan Schüberg and Mark Iwicki, president and chief operating officer of Sunovion Pharmaceuticals.
You may also be interested in...
Pharma Guidelines, ending 1 July 2011
Recently updated and newly issued documents
EuropaBio appoints new chairman
EuropaBio, the European biotech industry association, has appointed Stephan Tanda as its new association chair. Mr Tanda, a member of the managing board of life sciences and materials sciences firm DSM, succeeds GlaxoSmithKline's Andrea Rappagliosi, who will remain a member of the EuropaBio board.
Medtech Guidelines, ending 24 June 2011
Recently updated and newly issued documents